You might like
Concert shares soar as it bests Vertex cystic fibrosis drug in Phase 1 trial bizjournals.com/boston/blog/bi… via @BosBizJournal
Cambridge biotech startup to focus on muscle diseases with first drug bizjournals.com/boston/blog/bi… via @BosBizJournal
These Mass. researchers are receiving MacArthur 'genius grants' for 2015 bizjournals.com/boston/news/20… via @BosBizJournal
Verastem Stops Study of Experimental Cancer Therapy Stock Plunges biospace.com/News/verastem-…
Intarcia Buys One Month Old Startup Phoundry biospace.com/News/newborn-p…
Kelvin Lam, from Reaction Biology and Simplex Pharma, continue the conversation with Kelvin about kinases and epigenetics #BostonDOT15
NIH researchers find role for soft palate in adaptation of transmissible influenza viruses: Study improves und... 1.usa.gov/1OSfkZq
An arthritis drug demos potential to help reverse Alzheimer's disease. fiercebiotechresearch.com/story/arthriti…
Imperial team targets a key culprit involved in Parkinson's. fiercebiotechresearch.com/story/imperial… by @JohnCFierce
NHGRI grants to help ID variants in genome's regulatory regions that affect disease risk. 1.usa.gov/1L1f1M8
Allergan and Richter win FDA approval for a once-rejected schizophrenia pill. fiercebiotech.com/story/allergan… $AGN
ICYMI: Advaxis gets a whiplash after its upbeat assessment of PhII cancer vaccine data. fiercebiotech.com/story/advaxis-… by @JohnCFierce $ADXS
Immune Cells May Help Fight Against Obesity cell.com/immunity/abstr…
U.K. investigators say diabetes drug may target pancreatic cancer stem cells. fiercebiotechresearch.com/story/uk-inves…
UNC Parkinson's team develops smart immune cells to deliver neuroprotective proteins. fiercebiotechresearch.com/story/unc-park…
NantWorks Acquires Exclusive Rights To Amgens Amg 337 In Phase 2 For Gastric And Esophageal Cancers biospace.com/News/nantworks…
Eli Lilly Plans to Hire After Nabbing An Additional 6000 Square Feet of Space in Crowded Kendall Square biospace.com/News/eli-lilly…
Cell-Cycle Control of Bivalent Epigenetic Domains Regulates the Exit from Pluripotency: Stem Cell Reports cell.com/stem-cell-repo…
Star team at Wyss, MIT orchestrate wider use of CRISPR/Cas9 tech. fiercebiotechresearch.com/story/star-tea… by @JohnCFierce
Novartis AG and Googles Life Sciences to Test Smart Contact Lens in People in 2016 biospace.com/News/novartis-…
United States Trends
- 1. Minneapolis N/A
- 2. Mike McCarthy N/A
- 3. Frey N/A
- 4. Liverpool N/A
- 5. Rooney N/A
- 6. National Guard N/A
- 7. 2nd Amendment N/A
- 8. Bournemouth N/A
- 9. Border Patrol N/A
- 10. Slot N/A
- 11. Armed N/A
- 12. Abolish ICE N/A
- 13. Kim English N/A
- 14. Murder N/A
- 15. UConn N/A
- 16. #BOULIV N/A
- 17. Second Amendment N/A
- 18. Federal Agents N/A
- 19. Resisting N/A
- 20. Art II N/A
Something went wrong.
Something went wrong.